Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsCareOregon Hepcludex Prior Authorization | OpenPay…
    Ask Trek AI about this page
    CurrentCareOregonPolicy N/A

    Hepcludex Prior Authorization Guideline

    Customize your policy alerts

    Sign up for all careoregon policy alerts

    Know when careoregon releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs prior authorization and reauthorization for Hepcludex used to treat chronic hepatitis D infection. It applies to providers requesting coverage through CareOregon.

    Policy Summary
    PayerCareOregon
    PolicyHepcludex Prior Authorization Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Next Review DateN/A
    Key ActionSubmit documentation of chronic hepatitis D infection and prescribing by or consultation with a gastroenterologist or hepatologist for initial authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12 monthsApproval length
    2Therapy stages
    Chronic hepatitis DCovered diagnosis
    2Eligible specialists

    Hepcludex Coverage Criteria

    Initial Authorization

    Covered for initial authorization when all of the following are met:

    Initial authorization

    • Diagnosis of chronic hepatitis D infection
    • ONE of the following specialist requirements

      • Gastroenterologist: A gastroenterologist
      • Hepatologist: A hepatologist

    Reauthorization

    Covered for reauthorization when at least one of the following is documented:

    Policy Summary
    PayerCareOregon
    PolicyHepcludex Prior Authorization Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Next Review DateN/A
    Key ActionSubmit documentation of chronic hepatitis D infection and prescribing by or consultation with a gastroenterologist or hepatologist for initial authorization.
    SourceLink
    On This Page
    Hepcludex Coverage CriteriaAuthorization and Documentation RequirementsHepcludex Initial AuthorizationHepcludex Reauthorization

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ONE of the following response criteria

    • HDV RNA response: Reduction in HDV RNA levels
    • ALT response: Reduction or normalization of ALT lab values from baseline

    Authorization and Documentation Requirements

    Prior Authorization

    Initial Authorization Criteria

    Initial authorization requires a diagnosis of chronic hepatitis D infection and prescribing by, or consultation with, a qualified specialist.

    • Diagnosis of chronic hepatitis D infection
    • Prescribed by or in consultation with a gastroenterologist or hepatologist
    Documentation Required

    Reauthorization Documentation

    Reauthorization requires medical record documentation demonstrating treatment response during the authorization period.

    • Document response in the medical record before requesting reauthorization
    Documentation Required

    Reauthorization Response Evidence

    Submit evidence of treatment response showing a reduction in HDV RNA levels and/or a reduction or normalization of ALT laboratory values from baseline.

    • Reduction in HDV RNA levels
    • Reduction or normalization of ALT lab values from baseline

    Hepcludex Initial Authorization

    Hepcludex Initial Authorization

    Initial authorization requires all listed criteria:

    Initial authorization

    • Chronic hepatitis D diagnosis: Diagnosis of chronic hepatitis D infection
    • ONE of the following eligible specialists

      • Gastroenterologist: A gastroenterologist
      • Hepatologist: A hepatologist

    Hepcludex Reauthorization

    Hepcludex Reauthorization

    Reauthorization requires medical record documentation of at least one response criterion:

    ONE of the following documented responses

    • HDV RNA reduction: Reduction in HDV RNA levels
    • ALT improvement: Reduction or normalization of ALT lab values from baseline